In this project, we will evaluate the use and performance of a CE-marked device (wearable), which uses sensors to measure breathing rate, pulse rate, skin temperature, and heart rate variability for the purpose of early detection...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
RADAR-CNS
Remote Assessment of Disease and Relapse in Central Nervous...
26M€
Cerrado
TED2021-131536B-I00
MONITORIZACION INTELIGENTE Y CONTINUA DE PACIENTES RESPIRATO...
142K€
Cerrado
SOMNIO
Replacing sleep labs The first clinical grade home based di...
4M€
Cerrado
NIGHTINGALE
Connecting Patients and Carers using wearable sensor technol...
5M€
Cerrado
ARCHANGEL
Advanced Remote Continuous patient Health mANaGemEnt SoLutio...
3M€
Cerrado
PID2021-126455OB-I00
ECOSISTEMA DE SALUD INTELIGENTE PARA EL MANEJO DE ENFERMEDAD...
176K€
Cerrado
Información proyecto COVID-RED
Duración del proyecto: 26 meses
Fecha Inicio: 2020-10-16
Fecha Fin: 2022-12-31
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
In this project, we will evaluate the use and performance of a CE-marked device (wearable), which uses sensors to measure breathing rate, pulse rate, skin temperature, and heart rate variability for the purpose of early detection and monitoring of COVID-19 in general and high-risk populations. At the same time, a mobile application will be used to track participant-reported symptoms. A prospective, observational study will follow 13,000 individuals from the general population and 7,000 high-risk individuals wearing the device and responding to participant self-report parameters via a purpose-designed app. Based on this data, an algorithm will indicate which individuals likely require general practitioner (GP) care (for COVID-19 diagnostic testing, further vital signs assessment, and/or treatment) and/or hospital care. To evaluate algorithm performance, the cohort will be tested for COVID-19 antibodies at the end of follow-up. COVID-19 seropositivity in the intervention cohort will be compared seropositivity in a control population of 20,000 individuals drawn from the same populations using the application only. Thus, this project will deliver a large body of information on COVID-19 PCR testing and antibodies that can be used to develop additional diagnostics and therapeutics in addition to validating remote vital signs and self-reported symptoms monitoring systems.